محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Recurso digital |
| اللغة: | |
| منشور في: |
Zenodo
2026
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.5281/zenodo.19213671 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
جدول المحتويات:
- <p><strong>Novel Macromolecular Targeted Chemoprotective Preparation</strong><br>This breakthrough macromolecular agent is engineered for systemic protection and efficacy enhancement during solid tumor chemotherapy.<br> Versatile Delivery: Supports oral administration (crosses the gastrointestinal barrier, bypassing hepatic first-pass degradation), IV, and subcutaneous injection.<br> Clinical Indications: Specifically antagonizes chemotherapy-induced toxicities in parenchymal organs (cardiac, hepatorenal, auditory), repairs the blood-brain barrier to alleviate neuropathy, and arrests bone marrow senescence to mitigate severe suppression.<br> Dual Mechanism: * Healthy Tissue Shield: Provides spatial isolation and neutralizes free radicals to protect normal cells.<br> - Microenvironment Remodeling: Inhibits cancer stem cell metabolism and lifts immunosuppression without compromising chemotherapeutic lethality.<br> Core Advantages: Features high specificity with minimal off-target rates and stable pharmacokinetics. The molecular conformation is robust, supporting high-temperature sterilization and long-term cold-chain storage with excellent multi-drug compatibility.<br>Currently seeking co-development with pharmaceutical companies.<br>E-mail: research@laplacedemon-lab.com</p>